Modern Leaf - your cannabis guide

SOURCES

  • mdBriefcase, Cannabis IQ
  • Advancing Practice, Medical Cannabis Program (CCCEP Accredited)

     

  • Abramovici H, Chief H-O, Bureau R, et al. Information for healthcare Professionals. https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-use-marijuana/information-medical-practitioners/information-health-care-professionals-cannabis-marihuana-marijuana-cannabinoids.html. Accessed November 25, 2016
  • Arruda, D. C., Dalexandri, F. L., Katzin, A. M., & Uliana, S. R. (2005). Antileishmanial Activity of the Terpene Nerolidol. Antimicrobial Agents and Chemotherapy, 49(5), 1679-1687. doi:10.1128/aac.49.5.1679-1687.2005
  • Bab, I. (2011). Themed issue on cannabinoids in biology and medicine. British Journal of Pharmacology, 163(7), 1327-1328. doi:10.1111/j.1476-5381.2011.01536.x
  • Cervantes, J. (2007). Marijuana horticulture: The indoor/outdoor medical growers bible. Vancouver, B.C.: Van Patten
  • Chen Y, Buck J: Cannabinoids protect cells from oxidative cell death: A receptorindependent mechanism. J Pharmacol Exp Ther(2000)
  • Childs, E., Lutz, J. A., & Wit, H. D. (2017). Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug and Alcohol Dependence, 177, 136-144. doi:10.1016/j.drugalcdep.2017.03.030
  • Clarke, R., & Merlin, M. (2013). Cannabis: Evolution and Ethnobotany. University of California Press
  • Crean, R. D., Crane, N. A., & Mason, B. J. (2011). An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions. Journal of Addiction Medicine, 5(1), 1-8. doi:10.1097/adm.0b013e31820c23fa
  • Crippa, J., & Zuardi, A. (2007). Anxiolytic effects of cannabidiol. European Psychiatry, 22. doi:10.1016/j.eurpsy.2007.01.085
  • Ditchfield, J. (2014). The medical cannabis guidebook: The definitive guide to using and growing medical marijuana. San Francisco, CA: Green Candy Press
  • Drews, E., & Zimmer, A. (2012). The endogenous cannabinoid system. E-Neuroforum, 18(4). doi:10.1007/s13295-012-0036-7
  • Gable RS (June 2004). "Comparison of acute lethal toxicity of commonly abused psychoactive substances" (PDF). Addiction. 99 (6): 686–96. doi:1111/j.1360-0443.2004.00744.x
  • Gieringer D: Cannabis vaporization: A promising strategy for smoke harm reduction. J Cannabis Ther (2001)
  • Grotenhermen F: Effects of cannabis and cannabinoids. In: Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential. Grotenhermen F, Russo R (Eds), The Haworth Integrative Healing Press, Oxford, UK (2002)
  • Hall W, Degenhardt L. The adverse health effects of chronic cannabis use. Drug Test Anal. 2014;6(1-2):39-45. doi:10.1002/dta.1506
  • Hampson AJ, Grimaldi M, Axelrod J, Wink D: Cannabidiol and (-)∆9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA (1998)
  • Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J: Neuroprotective antioxidants from marijuana. Ann NY Acad Sci(2000)
  • Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW: Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology (2001)
  • Health Canada Government of Canada. Medical Use of Marijuana - Drugs and Health Products - Health Canada. http://www.hc-sc.gc.ca/dhp-mps/marihuana/index-eng.php. Published June 13, 2005. Accessed December 13, 2014
  • Herning RI, Hooker WD, Jones RT: Tetrahydrocannabinol content and differences in marijuana smoking behavior.Psychopharmacology (1986)
  • Hirliman, G. (Producer), & Gasnier, L.J. (Director). (1936). Reefer Madness [Motion Picture]. United States
  • Howlett AC. 1995. Pharmacology of cannabinoid receptors. Annual Review of Pharmacology and Toxicology
  • Health Canada, 2013: Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids. (2013, June 12). Retrieved January 05, 2018, from http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
  • Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ: Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther (1992)
  • Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR . Meta-analysis of cannabis based treatments for neuropathic and multiple-sclerosis-related pain . Curr Med Res Opin . 2007;23(1):17-24 . doi: 10 .1185/030079906X158066
  • Jones RT, Benowitz NL, Herning RI: Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol (1981)
  • Kelly P, Jones RT: Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J Anal Toxicol (1992) 16(4):228-235
  • Lee, M. A. (2012). Smoke Signals: A Social History of Marijuana - Medical, Recreational and Scientific. Scribner
  • Li HL: An archaeological and historical account of cannabis in China. Econ Bot (1974)
  • Liberal Party of Canada. (2018). Marijuana. Retrieved January 14, 2018, from https://www.liberal.ca/realchange/marijuana/
  • Mack, A., & Joy, J. E. (2001). Marijuana as medicine?: The science beyond the controversy. Washington, D.C.: National Academy Press
  • Manzanares, J., Julian, M., & Carrascosa, A. (2006). Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes. Current Neuropharmacology, 4(3), 239-257. doi:10.2174/157015906778019527
  • Matthias P, Tashkin DP, Marques-Magallanes JA, Wilkins JN, Simmons MS: Effects of varying marijuana potency on deposition of tar and ∆9-THC in the lung during smoking. Pharmacol Biochem Behav(1997)
  • Mechoulam R, Parker LA. The Endocannabinoid System and the Brain. Annu Rev Psychol. 2013;64(1):21-47. doi:10.1146/annurev-psych-113011-143739
  • Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A . Selective cannabinoids for chronic neuropathic pain: A systematic review and meta-analysis . Anesth Analg . 2017;125(5):1638-52 . doi: 10 .1213/ANE .0000000000002110
  • Mechoulam, R., Spatz, M., & Shohami, E. (2002). Endocannabinoids and Neuroprotection. Science Signaling, 2002(129). doi:10.1126/scisignal.1292002re5
  • Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA: Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci (1999)
  • Oleson, E. B., & Cheer, J. F. (2012). A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking. Cold Spring Harbor Perspectives in Medicine, 2(8). doi:10.1101/cshperspect.a012229
  • Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E: An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature (2001)
  • Pertwee, R. G. (2014). Handbook of cannabis: Edited by Roger G. Pertwee. New York: Oxford University Press
  • Raber, J. C., Elzinga, S., & Kaplan, C. (2015). Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of Toxicological Sciences, 40(6), 797-803. doi:10.2131/jts.40.797
  • Rice AS: Cannabinoids and pain. Curr Opin Invest Drugs (2001)
  • Robson P: Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry (2001)
  • Rosenthal, E., & Downs, D. (2014). Beyond buds: Marijuana extracts - hash, vaping, dabbing, edibles & medicines. Piedmont, CA: Quick American
  • Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. doi:10.1111/j.1476-5381.2011.01238.x
  • Russo, E. (2003). Cannabis: From pariah to prescription. Binghamton, NY: Haworth Herbal Press
  • Sartim, A., Guimarães, F., & Joca, S. (2016). Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors. Behavioural Brain Research, 303, 218-227. doi:10.1016/j.bbr.2016.01.033
  • Schecter, D. (2015). An Introduction to Cannabinoids in Clinical Practice
  • Schier AR, et al. (2014). Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. Institute of Psychiatry - Federal University of Rio de Janeiro
  • Shafer, R. P. (1972). Marihuana: A signal of misunderstanding: The official report of the National Commission on Marihuana and Drug Abuse. New York: New American Library
  • Small, E. (2016). Cannabis: A Complete Guide. Taylor & Francis Group
  • Stevens AJ, Higgins MD. A systematic review of the analgesic efficacy of cannabinoid medications in the management of acute pain . Acta Anaesthesiol Scand . 2017;61(3):268-80 . doi: 10 .1111/aas .12851
  • “The Marihuana Tax Act of 1937: Statement of Harry J. Anslinger". Schaffer Library of Drug Policy. Retrieved December 14, 2016
  • Walsh, Z., Gonzalez, R., Crosby, K., Thiessen, M. S., Carroll, C., & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15-29. doi:10.1016/j.cpr.2016.10.002
  • Wang T, Collet J-P, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ Can Med Assoc J. 2008;178(13):1669-1678. doi:10.1503/cmaj.071178